Dr Kyle J Kalkwarf, MD | |
4301 W Markham St # 520-1, Little Rock, AR 72205-7199 | |
(501) 526-6262 | |
Not Available |
Full Name | Dr Kyle J Kalkwarf |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 13 Years |
Location | 4301 W Markham St # 520-1, Little Rock, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730471376 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0127X | Surgery - Trauma Surgery | E-11429 (Arkansas) | Secondary |
208600000X | Surgery | Q7900 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Uams Medical Center | Little rock, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Arkansas | 4082528955 | 1121 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.
Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 percent compared to standard treatment, according to new findings.
Children with HIV have persistently high levels of cholesterol and other lipids during treatment with antiretroviral medications, according to a pair of studies in JAIDS: Journal of Acquired Immune Deficiency Syndromes.
NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that it will deliver two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA).
› Verified 8 days ago
Entity Name | University Of Arkansas For Medical Sciences |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.
Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 percent compared to standard treatment, according to new findings.
Children with HIV have persistently high levels of cholesterol and other lipids during treatment with antiretroviral medications, according to a pair of studies in JAIDS: Journal of Acquired Immune Deficiency Syndromes.
NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that it will deliver two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kyle J Kalkwarf, MD 4301 W Markham St # 520-1, Little Rock, AR 72205-7199 Ph: (501) 526-6262 | Dr Kyle J Kalkwarf, MD 4301 W Markham St # 520-1, Little Rock, AR 72205-7199 Ph: (501) 526-6262 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.
Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 percent compared to standard treatment, according to new findings.
Children with HIV have persistently high levels of cholesterol and other lipids during treatment with antiretroviral medications, according to a pair of studies in JAIDS: Journal of Acquired Immune Deficiency Syndromes.
NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that it will deliver two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA).
› Verified 8 days ago
Dr. Jennifer Ann Minneman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 N University Ave Ste 203, Little Rock, AR 72205 Phone: 501-664-2434 | |
Charles Wesley Wagner, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 12609 Saint Charles Blvd, Little Rock, AR 72211 Phone: 501-680-0738 | |
Mrs. Elaine Marie Thrash, PA Surgery Medicare: Accepting Medicare Assignments Practice Location: 8901 Carti Way, Little Rock, AR 72205 Phone: 501-906-3000 | |
Oleksiy Gudz, M.D.,PHD Surgery Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 520-2, Little Rock, AR 72205 Phone: 501-686-6086 Fax: 501-686-5328 | |
Dr. Jonathan Amarkwei Laryea, MB CHB Surgery Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot 520, Little Rock, AR 72205 Phone: 501-686-6648 Fax: 501-686-7280 | |
Dr. Jordan W Greer, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 4110 Outpatient Circle, Outpatient Center, Third Floor, Little Rock, AR 72205 Phone: 501-686-6086 Fax: 501-686-5855 | |
David Sayre Bard, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 9501 Lile Drive, Ste 777, Little Rock, AR 72205 Phone: 501-228-7779 Fax: 501-228-7877 |